Dyslipidaemia and inflammation are risks for subclinical atherosclerotic vascular disease among chronic kidney failure patients in South Africa
The burden of inflammation and lipoprotein abnormalities was greatest among end stage kidney disease (ESKD) patients and was the highest in CAPD patients. Lipoprotein(a) independently predicted AsVD.
Authors
- Raquel Duarte (ORCID: https://orcid.org/0000-0003-2257-3099)
- Muzamil Hassan (ORCID: https://orcid.org/0000-0001-8317-5241)
- Caroline Dickens (ORCID: https://orcid.org/0000-0002-4080-624X)
- Kebashnee Moodley (ORCID: https://orcid.org/0000-0002-8515-4775)
- Stephen Olawale Oguntola (ORCID: https://orcid.org/0000-0001-5442-6195)
- Gbenga Olorunfemi (ORCID: https://orcid.org/0000-0001-6634-8550)
- Tracy Snyman
- Thérèse Dix‐Peek (ORCID: https://orcid.org/0000-0002-7593-0857)
- Pravin Manga (ORCID: https://orcid.org/0000-0002-2709-2158)
- Saraladevi Naicker (ORCID: https://orcid.org/0000-0002-7058-9725)
- Ahmed Vachiat (ORCID: https://orcid.org/0000-0002-4104-0258)
Institutions
- University of the Witwatersrand (ZA)
- Afe Babalola University (NG)
- Osun State University (NG)
- Obafemi Awolowo University (NG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1371/journal.pone.0323882
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00